The article says GLP-1 drugs carry black-box warnings for medullary thyroid carcinoma risk observed in animal models, and that they are contraindicated in anyone with a personal or family history of thyroid cancer or MEN 2 syndrome
Trial data on retatrutide is super promising, and the grey market seems to have lost interest in first-to-market GLP-1 Ozempic
Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, et al
The STEP 1 trial data revealed that 38% of weight lost on semaglutide came from lean body mass, not fat
They will adjust or decrease your dose or switch the medication
Allow the peptide to dissolve naturally over 1-2 minutes